Oracle co-founder Larry Ellison is betting big on AI’s potential to revolutionize cancer treatment, calling it one of the most promising frontiers in medicine. Speaking about his company’s latest efforts at the White House recently, Ellison described a groundbreaking approach to early detection and personalized treatment that could redefine how the world fights cancer.
“All of our cancers — cancer tumors — little fragments of those tumors float around in your blood,” Ellison stated. “So you can do early cancer detection using AI to look at the blood test, you can find the cancers that are actually seriously threatening the person.” This method, he explained, turns AI into an invaluable tool for identifying cancers before they become untreatable.
Beyond detection, AI is also accelerating the development of personalized cancer vaccines.
“Once we gene sequence that cancer tumor, you can then vaccinate the person — design a vaccine for every individual person to vaccinate them against that cancer,” Ellison explained. The most astonishing aspect? “You can make that mRNA vaccine using AI in about 48 hours.”
Ellison’s vision is one where AI-driven medicine leads to earlier diagnoses and faster, more effective treatments, transforming the battle against cancer as we know it.
Featured image: Credit: Oracle PR Hartmann Studios, Wikipedia
